Ulrich Dührsen Selected Research

Ulrich Dührsen Research Topics

Disease

25	Lymphoma (Lymphomas) 04/2024 - 10/2004
25	Neoplasms (Cancer) 01/2024 - 01/2002
13	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 03/2012
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 04/2004
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2008
9	Leukemia 04/2024 - 05/2009
8	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2020 - 12/2007
8	Disease Progression 01/2017 - 04/2003
7	Multiple Myeloma 04/2024 - 08/2010
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 03/2005
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2018
6	Hemolysis 01/2020 - 06/2011
4	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 10/2010
4	Infections 01/2024 - 02/2005
4	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 08/2013
4	Aplastic Anemia (Anemia, Hypoplastic) 07/2019 - 04/2011
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2018 - 01/2002
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2024 - 03/2005
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2022 - 02/2017
3	Heart Failure 01/2022 - 01/2006
3	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2019 - 04/2009
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 04/2024 - 12/2023
2	Paraproteinemias (Monoclonal Gammopathy) 04/2024 - 12/2023
2	Large Granular Lymphocytic Leukemia 01/2023 - 11/2022
2	Residual Neoplasm 12/2021 - 10/2008
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 12/2020 - 01/2020
2	Febrile Neutropenia 08/2016 - 03/2012
2	Sepsis (Septicemia) 10/2013 - 04/2007
2	Anemia 06/2013 - 12/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2013 - 05/2007
2	Carcinogenesis 01/2013 - 11/2006
2	Philadelphia Chromosome 05/2009 - 05/2007
1	Stomatitis 11/2023
1	Skin Neoplasms (Skin Cancer) 10/2023
1	Overweight 10/2023
1	Aspergillosis 06/2023
1	T-Cell Leukemia (Leukemia, T Cell) 11/2022
1	Pathologic Complete Response 10/2022
1	Cytokine Release Syndrome 11/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2021

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 03/2024 - 10/2004
12	Prednisone (Sone)FDA LinkGeneric 11/2020 - 03/2005
9	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 03/2005
9	eculizumab FDA Link 01/2020 - 12/2007
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 03/2005
8	Vincristine (Oncovin)FDA LinkGeneric 11/2020 - 03/2005
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2006
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 11/2009
5	Complement Inactivating AgentsIBA 04/2017 - 12/2007
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2016 - 05/2009
4	Circulating Tumor DNAIBA 01/2023 - 10/2018
4	Complement System Proteins (Complement)IBA 10/2019 - 05/2005
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2016
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2017 - 06/2006
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2011 - 01/2002
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2017
3	Bortezomib (Velcade)FDA Link 01/2021 - 01/2012
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 10/2016
3	Alemtuzumab (Campath)FDA Link 12/2020 - 05/2005
3	CytokinesIBA 01/2020 - 01/2006
3	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 08/2013
3	Bleomycin (Blenoxane)FDA LinkGeneric 11/2019 - 08/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2019 - 04/2011
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 07/2019 - 04/2011
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2009
2	Gemcitabine FDA Link 03/2024 - 11/2005
2	Chimeric Antigen ReceptorsIBA 01/2023 - 11/2021
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2022 - 09/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 04/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 11/2018
2	Anaplastic Lymphoma KinaseIBA 09/2021 - 08/2020
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 08/2016
2	Immunoglobulins (Immunoglobulin)IBA 10/2019 - 08/2006
2	Azacitidine (5 Azacytidine)FDA Link 12/2018 - 01/2012
2	Procarbazine (Matulane)FDA Link 01/2017 - 08/2013
2	Messenger RNA (mRNA)IBA 12/2009 - 06/2009
2	fludarabineIBA 08/2009 - 05/2005
2	Imatinib Mesylate (Gleevec)FDA Link 05/2009 - 05/2007
2	HLA-G Antigens (HLA G)IBA 12/2007 - 02/2005
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024
1	Immunoglobulin M (IgM)IBA 12/2023
1	Decitabine FDA Link 11/2023
1	LipidsIBA 10/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 12/2021
1	axicabtagene ciloleucelIBA 11/2021
1	tocilizumab (atlizumab)FDA Link 11/2021
1	Fluorine-18IBA 10/2021

Therapy/Procedure

40	Therapeutics 03/2024 - 10/2004
19	Drug Therapy (Chemotherapy) 03/2024 - 04/2003
9	Stem Cell Transplantation 03/2024 - 01/2012
4	Aftercare (After-Treatment) 04/2024 - 10/2019
4	Homologous Transplantation 04/2024 - 08/2020
3	Radiotherapy 10/2023 - 10/2004
2	Hematopoietic Stem Cell Transplantation 12/2020 - 10/2013
2	Salvage Therapy 01/2020 - 01/2019
2	Transplantation 10/2013 - 04/2011
1	Organ Transplantation 10/2022